title: Cefuroxime axetil in the treatment of acute otitis media in children.
abstract: Cefuroxime axetil was evaluated for clinical efficacy and tolerance in the treatment of acute otitis media in children. Fifty-five children, 5.0 to 10.8 years, were randomly assigned to receive 250mg cefuroxime axetil every 12 hours or 50mg/kg/day amoxicillin in three divided doses. Both treatment schemes lasted for 10 days. Acute otitis media was diagnosed by the presence of erythema and/or opacity with bulging of the tympanic membrane. A tympanogram was obtained upon enrollment to the study, as well as within 2 days after completion of therapy. Fifty-one children completed the treatment protocol. The cure rate was 74.1% for cefuroxime axetil and 75.0% for amoxicillin. Clinical improvement was noted in 25.9% of children treated with cefuroxime axetil and in 25.0% of those treated with amoxicillin. There was no clinical failure in the two treatment groups. None of the children experienced relapse of acute otitis media during the month following completion of therapy. The findings indicate that cefuroxime axetil given twice daily has comparable efficacy to amoxicillin given three times daily in the treatment of children with acute otitis media.
authors.affiliation: Department of Pediatrics, University of Patras, School of Medicine, Greece.
authors.forename: G A
authors.initials: GA
authors.lastname: Syrogiannopoulos
authors.forename: P D
authors.initials: PD
authors.lastname: Goumas
authors.forename: F A
authors.initials: FA
authors.lastname: Haliotis
authors.forename: C G
authors.initials: CG
authors.lastname: Lygatsikas
authors.forename: C D
authors.initials: CD
authors.lastname: Spyropoulos
authors.forename: N G
authors.initials: NG
authors.lastname: Beratis
mesh_terms: D000208:Acute Disease; D000658:Amoxicillin / Q000009:adverse effects / Q000627:therapeutic use; D002444:Cefuroxime / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D010033:Otitis Media / Q000188:drug therapy*; D010034:Otitis Media with Effusion / Q000188:drug therapy; D011355:Prodrugs / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies
chemical_list: D011355:Prodrugs; D000658:Amoxicillin; D002444:Cefuroxime; C040738:cefuroxime axetil